Ucb Biosciences, Inc.
Clinical trials sponsored by Ucb Biosciences, Inc., explained in plain language.
-
New hope for babies with severe epilepsy: drug trial targets dravet syndrome
Disease control OngoingThis study tests the safety of fenfluramine in 25 infants aged 1 to 2 years with Dravet syndrome, a severe form of epilepsy. The medicine is given daily alongside other seizure drugs to help control seizures. The goal is to see if it is safe and well-tolerated in this young age g…
Phase: PHASE3 • Sponsor: UCB BIOSCIENCES, Inc. • Aim: Disease control
Last updated May 26, 2026 12:12 UTC
-
New hope for kids with rare muscle-wasting disease as drug combo moves to next phase
Disease control OngoingThis study tests two oral medications, doxecitine and doxribtimine, in 47 people with thymidine kinase 2 (TK2) deficiency, a rare genetic disorder that causes severe muscle weakness. Participants are already receiving similar treatment and will continue under close monitoring. Th…
Phase: PHASE2 • Sponsor: UCB BIOSCIENCES, Inc. • Aim: Disease control
Last updated May 26, 2026 12:08 UTC